Safety assessment of a solid lipid curcumin particle preparation: In vitro and in vivo genotoxicity studies
Journal of Applied Toxicology · 2023-06 · 43 (6) · 929-939
DOI: 10.1002/jat.4434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, online erschienen am 15.01.2023. Verfasst von Kirt R Phipps und 4 weiteren Autor:innen. Beteiligte Einrichtung: Intertek Health Sciences Inc., Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, GU14 0LX, UK. Hauptthemen laut MEDLINE: Chromosome Aberrations, Curcumin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben.
Abstract (Originalsprache)
Curcumin, one of the three principal curcuminoids found within turmeric rhizomes, has long been associated with numerous physiologically beneficial effects; however, its efficacy is limited by its inherently low bioavailability. Several novel formulations of curcumin extracts have been prepared in recent years to increase the systemic availability of curcumin; Longvida®, a solid lipid curcumin particle preparation, is one such formulation that has shown enhanced bioavailability compared with standard curcuminoid extracts. As part of a safety assessment of Longvida® for use as a food ingredient, a bacterial reverse mutation test (OECD TG 471) and mammalian cell erythrocyte micronucleus test (OECD TG 474) were conducted to assess its genotoxic potential. In the bacterial reverse mutation test, Longvida® did not induce base‐pair or frame‐shift mutations at the histidine locus in the genome of Salmonella typhimurium strains TA98, TA100, TA102, TA1535, and TA1537, in the presence or absence of exogenous metabolic activation. Additionally, two gavage doses (24 h apart) of Longvida® to Swiss albino mice at 500, 1000, or 2000‐mg/kg body weight/day did not cause structural or numerical chromosomal damage in somatic cells in the mammalian erythrocyte micronucleus test. It was therefore concluded that Longvida® is non‐genotoxic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Intertek Health Sciences Inc., Room 1036, Building A8, Cody Technology Park, Ively Road, Farnborough, Hampshire, GU14 0LX, UK.
- Intertek Health Sciences Inc., 2233 Argentia Road, Suite 201, Mississauga, Ontario, L5N 2X7, Canada.
- Pre-Clinical Department, Cadila Pharmaceuticals Ltd., 1389 Trasad Road, Dholka, Ahmedabad, 382 225, India.
ORCID-Profile: Kirt R Phipps
Zitieren
APA
Phipps, K. R., Bali, V., Kukadia, D., Patel, C., & Muchhara, J. (2023). Safety assessment of a solid lipid curcumin particle preparation: In vitro and in vivo genotoxicity studies. Journal of Applied Toxicology, 43(6), 929-939. https://doi.org/10.1002/jat.4434
Vancouver
Phipps KR, Bali V, Kukadia D, Patel C, Muchhara J. Safety assessment of a solid lipid curcumin particle preparation: In vitro and in vivo genotoxicity studies. Journal of Applied Toxicology. 2023;43(6):929-939. doi:10.1002/jat.4434
BibTeX
@article{Phipps2023,
author = {Phipps, Kirt R and Bali, Victoria and Kukadia, Dhaval and Patel, Chintan and Muchhara, Jayesh},
title = {Safety assessment of a solid lipid curcumin particle preparation: In vitro and in vivo genotoxicity studies},
journal = {Journal of Applied Toxicology},
year = {2023},
volume = {43},
number = {6},
pages = {929--939},
doi = {10.1002/jat.4434}
}
EUVIMED